Jiangsu Chenpai Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Chenpai Pharmaceutical Group") was founded in 1996. Its predecessor was Haimen Pharmaceutical Factory of Jiangsu Province. It is located in Haimen City, Jiangsu Province, with a registered capital of 55 million yuan, and has 2 controlled subsidiaries (Jiangsu Hanchen Pharmaceutical Co., Ltd. and Jiangsu Chenpai Bangde Pharmaceutical Co., Ltd.).
The company is mainly engaged in the production and sales of chemical drugs and Chinese patent medicine preparations in the fields of cardiovascular and cerebrovascular diseases, diabetes, nervous system, gynecology, pediatrics, etc. The group has three modern, multi-functional manufacturing bases. It has 165 drug approval numbers, including more than 10 exclusive medical insurance and exclusive product approval numbers. The product line covers large-volume injections, tablets, capsules, granules, external solutions, soft capsules, eye drops, etc., and all production lines have passed the new version of GMP verification. The company's products on sale are highly competitive, featuring a product group of major varieties, with dispersed tablets as the main dosage form, many potential varieties, and few competitors. The leading products include piracetam sodium chloride injection, ginkgo leaf tablets, voglibose dispersible tablets, etc.
Chenpai Group has been recognized as a high-tech enterprise of Jiangsu Province and a famous brand product of Jiangsu Province, and has been recognized by the State Food and Drug Administration as one of the top 100 Chinese pharmaceutical industrial enterprises in innovation capability and one of the top 100 Chinese traditional Chinese medicine industrial enterprises.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows